Literature DB >> 27917862

Purslane (Portulaca oleracea) Seed Consumption And Aerobic Training Improves Biomarkers Associated with Atherosclerosis in Women with Type 2 Diabetes (T2D).

Firouzeh Dehghan1, Rahman Soori1, Khadijeh Gholami2, Mitra Abolmaesoomi3, Ashril Yusof4, Sekaran Muniandy3, Sara Heidarzadeh, Parvin Farzanegi, Mohammad Ali Azarbayjani.   

Abstract

The aim of this study was to investigate the responses of atherosclerosis plaque biomarkers to purslane seed consumption and aerobic training in women with T2D. 196 women with T2D were assigned into; (1) placebo (PL), (2) aerobic training+placebo (AT + PL), 3) purslane seeds (PS), aerobic training+purslane seeds (AT + PS). The training program and purslane seeds consumption (2.5 g lunch and 5 g dinner) were carried out for 16 weeks. The components of purslane seed were identified and quantified by GC-MS. Blood samples were withdrawn via venipuncture to examine blood glucose, low-density lipoprotein (LDL), high-density lipoprotein (HDL), cholesterol, triglycerides (TG), creatinine, urea, uric acid, NF-κB, GLP1, GLP1R, TIMP-1, MMP2, MMP9, CRP, CST3, and CTSS expressions. Blood glucose, LDL, cholesterol, TG, creatinine, urea, and uric acid levels in the (P), (AT), and (AT + PS) groups were significantly decreased compared to the pre-experimental levels or the placebo group, while HDL, significantly increased. Furthermore, the protein and mRNA levels of NF-κB, TIMP-1, MMP2 &9, CRP, CST3, and CTSS in the (P), (AT), (AT + PS) significantly decreased compared to pre-experimental or the placebo group, while level of GLP1 and GLP1-R increased drastically. Findings suggest that purslane seed consumption alongside exercising could improve atherosclerosis plaque biomarkers through synergistically mechanisms in T2D.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27917862      PMCID: PMC5137030          DOI: 10.1038/srep37819

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Diabetes mellitus (DM) is a metabolic disease with 8% worldwide prevalence in 2011 whereby it’s prevalence estimated to reach 10% by 20301. DM is characterized by hyperglycemia, glucose intolerance, abnormal lipid and protein metabolisms along with specific long–term complications affecting several major organs, including heart, blood vessels, nerves, eyes, and kidneys. Diabetic complications, such as cardiac dysfunction, atherosclerosis, neuropathy, retinopathy, and nephropathy23 are linked to defective insulin secretion, insulin resistance, or both45. Patients with type 2 diabetes (T2D) are at higher risk of complications arising from macro vascular, peripheral vascular and coronary heart disease, stroke, and insulin resistance associated with atherosclerosis6. Atherosclerosis is a chronic inflammatory disease of blood vessels and it is characterized by formation of atherosclerotic plaques in arteries including calcified regions, necrotic cores, inflamed smooth muscle cells, accumulated modified lipids, endothelial cells, leukocytes, and foam cells7. Atherosclerosis causes cardiovascular diseases (CVD) in the components of the vascular, immune systems are involved8. Atherosclerosis diagnosis comprises of the identification of biomarkers linked to the development of this disease. Among the markers, nuclear factors kappa beta (NF-κB) and C-reactive protein (CRP) are the master key and prototypic markers respectively910. Activation of NF-κB is a key event in the pathobiology of diabetes and leads to apoptosis of beta cells. It is required for the transcription of inflammatory molecules containing adhesion molecule, cytokine and chemokines11. Matrix metalloproteinases (MMP) and cysteine proteases degrade extracellular matrix (ECM) proteins which are essential for vascular remodeling thus contributing to CVD121314. High levels of glucose, LDL, VLDL, and uric acid activate CRP and NF-κB pathways which increase the expression of MMP2, MMP9 and CTSS (Fig. 1)15161718. In addition, glucagon like peptide −1 (GLP-1) is an insulinotropic agent which improves beta cell functions19 and protects heart muscle cells against adverse cardiac remodeling20.
Figure 1

Schematic illustration of some of the key pathological pathways that are involved in both type 2 diabetes and atherosclerosis.

Hyperglycemia, hyperlipidemia, hyperinsulinia, and hyperuricimia increase ROS generation through oxidative stress. ROS activates a number of stress sensitive kinase which mediates insulin resistance via activation of NF-κB and CRP. On the other hand, activation of NF-κB and CRP affect the structure of extracellular matrix and increase the activity of MMP and cathepsin S which are involved in atherosclerosis and diabetes. Exercise and purslane intake improve the regulation of biomarkers involved in the activation of these pathways. TG; triglycerides, LDL; Low-density lipoprotein, ROS; reactive oxygen species, NF-κB; nuclear factor kappa-light-chain-enhancer of activated B cells, CRP; C-reactive protein, MMPs; Matrix metalloproteinase, TIMP-1; metallopeptidase inhibitor 1.

Maintaining a healthy life style with regular physical activity has shown to reduce complications resulting from T2D21. In recent years, attention has been given to alternative medicines such as herbal remedies for treating and preventing plenty different diseases such as T2D2223. Portulaca oleracea commonly known as purslane, is an herb from the Portulacaceae family with anti-diabetic properties5 and has been used for therapeutic purposes. It is listed by in the World Health Organization as one of the most used medicinal plants termed as ‘Global Panacea’24. P. oleracea is an excellent source of antioxidants such as vitamins A, C, E and β-carotene2526. Several studies have indicated purslane extract as a factor in lowering blood sugar, triglycerides, total cholesterol, high-density-lipoprotein (HDL), low-density-lipoprotein (LDL) and body weight in diabetic rat and mice2728. Moreover, consumption of purslane seeds alongside 8 weeks of resistance training by women with T2D, improved indicators associated with liver damage29, proxidant and antioxidant balance30 and blood pressure31. It also prevented exercise-induced oxidative stress30. Physical activities such as resistance training promote an increase in lean muscle mass, muscle strength, the basal metabolic rate and sensitivity to insulin in diabetic individuals32. Regular exercising affects the regulation of enzymatic antioxidants such as catalase, super oxide dismutase and non-enzymatic antioxidants including vitamin E and C. Regular exercise is linked to CRP reduction, lipid profile regulation, increase of nitric oxide synthase, improvement in insulin sensitivity, and preservation of beta cell mass. Thus regular exercise leads to the adaptation in antioxidant capacity, protecting cells against harmful effects of oxidative stress33. In this study our aim was to investigate the responses of atherosclerosis plaque biomarkers to purslane seed consumption (as non-medical intervention) along with aerobic training in women with T2D within a 16 week time period. We evaluated the lipid profile as well as traditional biomarkers and other biomarkers related with tissue inflammation and inflammatory response in diabetes patients including MMP 2&9, CRP, cystain C, creatinine, uric acid.

Patients and Methods

Subject recruitment

The study involved 196 women with type 2 diabetes whose fasting blood glucose levels were greater than 200 mg/dL (not taking metformin) and were diagnosed with the illness for an average of 8 years. The patients were on metformin with the dose of 500 mg/day and were registered with Tehran Hospital (Iran). Characteristics and demographics of the patients are presented in Table 1. The average age and BMI of these women were 52.08 ± 3.45 years and 29.5 ± 6.5 kg/m2 respectively. Eligible participants lacked any form of complications arising from acute and chronic diabetes and did not exercise regularly. The participants did not have any history of other diseases such as chronic cardiovascular and inflammatory diseases, diabetic ulcers, and hepatitis. Patients consuming vitamins and supplements or those who smoked were excluded from the study. Patients were well informed about the study prior to the experiment and written consent was obtained from them. A double-blind study method was applied and the participants were randomly assigned into 4 groups of 8; (1) placebo (PL), (2) aerobic training + placebo (AT + PL), (3) purslane seeds (PS), and (4) aerobic training + purslane seeds (AT + PS). All procedures involving experiments were carried out in strict accordance of the United States Institute of Research guidelines and approved by the Medical Centre Board of Tehran Hospital with Medical Ethics Number 4382.30.
Table 1

Characteristics and demographics of the diabetics’ subjects.

 Placebo (PL) Mean ± SEMAerobic Training + Placebo (AT + PL) Mean ± SEMPurslane Seeds (PS) Mean ± SEMAerobic Training + Purslane Seeds (AT + PS) Mean ± SEM
Age, year50.17 ± 5.3458.83 ± 6.7952.33 ± 4.0861.17 ± 4.88
Height, cm160.67 ± 6.44162.50 ± 6.53159.17 ± 6.65154.50 ± 10.60
Weight, cm75.67 ± 9.4479.50 ± 8.9673.50 ± 6.6570.83 ± 7.88
BMI, Kg/m229.8 ± 6.429.5 ± 7.229.0 ± 5.029.9 ± 7.3

Plant sample preparation

Purslane seeds were purchased from a grocery shop in Tehran (Iran). The seeds were washed and air dried at room temperature for seven days. The dry seeds were powdered and packaged in capsules (5 g each). Portulaca oleracea was identified and verified by a botanist and deposited at Herbarium of Department of Biochemistry, (voucher specimen no. 15–04979). The consumer groups (AT + PS, PS) consumed 2.5 g of purslane seeds with lunch and 5 g with dinner daily for 16 weeks. The placebo group similarly received placebo pills (the flavored maltodextrin).

Sample preparation and identification of compounds by Gas Chromatography/Mass Spectroscopy (GC/MS/MS)

Dried powdered (100 g) purslane seed was added with 100 ml of methanol and left at room temperature overnight. The eluate was filtered through Whatman filter paper and shade dried to remove the solvent. The extract was then weighed (0.563 g) and kept in −20 °C for further analysis. The extract was used in Gas Chromatography. The detail of Chromatography is available in supplementary file.

Aerobic training Guideline

Patients in groups AT + PL and AT + PS performed their training under a trainer’s supervision for 16 weeks in a gym. The trainer is blinded to the subject’s treatment group. Jogging was considered for this study as a moderate-intensity aerobic activity. Progressive training was performed for a minimum of 60 min per session for three days a week at 50 to 70% of maximum heart rate (MHR) during the 16 weeks of experiment. Written informed consent was obtained from all patients before any study-related procedures were performed. Patients were familiarized with the protocol and a heart rate strap was applied on them to monitor their heart rate within the first two sessions. The training included a 15 min warm-up through walking with light static and dynamic stretching and cooling down with stretching in standing and lying position in the final 15 min. All movements were performed with medium tempo and separate movement for arms, legs and trunk. The main training time increased 40 to 45 min and heart rate has reached 70% MHR. At the end of 16 weeks participants were able to perform muscle movements with greater coordination.

Blood Sample Collection

Blood samples were collected at the certain time of the trainings through the elbow antecubital vein of all patients, 24 hours before and after the 16 weeks training and purslane consumption for measurement of blood glucose, LDL, HDL, cholesterol, TG, creatinine, urea, uric acid, NF-κB, GLP1, GLP1R, TIMP-1, MMP2, MMP9, CRP, CST3, and CTSS mRNA and protein expressions.

Measurement of Serum parameters

Blood samples were collected in serum separating tubes (SST) and allowed to clot at room temperature for 30 min. The blood clot was then centrifuge at 3000 g for 15 min. Aliquots of the serum samples were stored at −20 °C for further use. Fasting serum glucose and total cholesterol levels were determined using the glucose oxidase method34 with a digital spectrophotometer (Spectronic, US). LDL level was calculated using the Friedewald equation35, and to measure HDL level, diagnosis kits were used following the photometric method. Serum triglycerides was measured by using the Fossati and Prencipe method36. Based on manufacturer’s instructions of Fortress Diagnostics Limited, creatinine, urea, and uric acid were examined by alkaline picrate method, urease-hypochlorite and uricase-peroxidase methods respectively. Enzyme-linked immunosorbent assay (ELISA) was performed by using commercial kits (CUSABIO - USA) for NF-κB, GLP-1, GLP1R, TIMP-1, MMP2, MMP9, CRP, CST3, and CTSS. The ELISA kits detail information are available in supplementary file.

RNA purification and mRNA Expression Analysis by Real Time PCR (qPCR)

QIAamp RNA Blood Mini Kit (Qiagen, Germany) was used to isolate total cellular RNA from fresh whole blood. The concentration and purification of isolated RNA were evaluated by 260/280 UV absorption ratios (Gene Quant 1300, UK). Specific amplification fragments of DNA/RNA, Two-step Real time qPCR (quantitative Polymerase Chain Reaction) technique was used to calculate gene expression during the PCR amplification process with application of TaqMan reagent. This method was able to detect small differences between samples compared to other methods37. All reagents including probes and primers were obtained from Applied Biosystems, USA. TaqMan probe (known as fluorogenic 5′ nuclease) was chosen to perform qPCR. This probe has a sensitivity of 100% and a specificity of 96.67%17 and is capable of detecting as few as 50 copies of RNA/ml and as low as 5–10 molecules18. The same company designed specific primers for specific targets. The primers detail information are available in supplementary file. All experiments were conducted in 3 biological replicates in a Step One Plus real time PCR machine (Applied Biosystems, USA). The Real time PCR program includes reverse transcription, at 48 °C for 15 min, activation of ampli Taq gold DNA polymerase at 95 °C for 10 min, denaturation at 95 °C for 15 sec and annealing at 60 °C for 1 min. Denaturation and annealing steps were performed for 40 cycles. The fold changes of each target per average of ACTB were calculated and considered as mRNA expression levels of the target gene. Data was analyzed according to Comparative Ct (2−ΔΔCt) method, where amplification of the target and the reference genes were measured in the sample and reference.

Statistical Analysis

Levene’s equality of variable assumption was applied and the results revealed no significant differences among the observations. All data were presented as mean ± SEM. Hormone levels of each subject were analyzed by descriptive statistics. Two-way analysis of variance with repeated measure (ANOVA) was used to compare changes between groups. A Bonferroni post-hoc test was used to check for significant differences between training alone vs. purslane seeds alone vs. aerobic + purslane seeds combined. For variables with normal distribution, Pearson correlation coefficient and for non-normal distributed variable, Spearman correlation coefficient were applied. SPSS 18.0 was used in this study and p < 0.05 was considered as statistically significant.

Results

Gas Chromatography/Mass Spectroscopy of Purslane Seed Extract

The components of Purslane seed were identified and quantified by GC–MS. A total of 21 known compounds are presented in Table 2. Among these compounds, 27% are unsaturated fatty acid (linoleic and palmitoleic acid); 11.18% are phytosterols (stiotestrol), and 7.9% are saturated fatty acids (palmitic acid). Additionally, smaller amounts of unknown substances were also detected (Fig. 2).
Table 2

Composition of total components contents of purslane seeds.

Peak #NameR.T. (s)AreaRelative Amount (RA)Mass
12-Propanol, 1-[(1-methylethyl) amino]-3-[2-(2-propenyl) phenoxy]-(Alprenolol, or alfeprol, alpheprol)252.153114490.04249
24-Methylpiperidine-1-carboxylic acid, phenyl ester (acid amin3)485.3563403940.81219
3N-(1-Methoxycarbonyl-1-methylethyl)-4-methyl-2-aza-1,3-dioxane582.2544772910.57203
4Tetrahydropyran-4-ol, 2,2-dimethyl-4-[[(thiophen-2-ylmethyl) amino]methyl]-717.912948735716.61255
51,3-Oxathiolane, 2-[[(2-chloroethyl) thio]methyl]-2-methyl-736.33880910.05212
6Benzoic acid, 2-(2-isopropyl-5-methylphenoxymethyl)-85364513120.83284
729.82 Methyl dodecanoate1684.5524104390.31214
8n-Hexadecanoic acid (Palmitic acid)1731.6619056297.94256
9Decanamide, N-(2-hydroxyethyl)-1925.3526863476.76215
109,12-Octadecadienoic acid (Z,Z)- Linoleic acid (LA)1927.412079253015.49280
119-Hexadecenoic acid-(Palmitoleic acid)1933.259373657512.02254
129,12,15-Octadecatrien-1-ol, (Z,Z,Z)-1934.05249341923.20264
13S-[2-[N,N-Dimethylamino]ethyl]N,N-dimethylcarbamoyl thiocarbohydroximate2074.541966780.54219
14Palmidrol2103.5104892241.35299
154-(7-Methoxy-7-methyloxepan-2-ylidene) butan-2-one2110.359206200.76212
166-Methoxy-2-methyl-quinoline-3-carboxylic acid 2-dimethylamino-ethyl ester2240.95165830582.13288
17Glycerol 1-palmitate2292.1246803403.17330
18Z-5,17-Octadecadien-1-ol acetate2453.77986244810.24308
199,12,15-Octadecatrien-1-ol, (Z,Z,Z)-2460.85294379873.78264
203H-Imidazo[4,5-b]pyridine, 2-(2-ethylhexylsulfanyl)-2753174940202.24263
21beta-Sitosterol3004.88715778911.18414
 Total 779,743,770100 
Figure 2

Chromatographic profile of purslane seed methanolic extract, the 21 known and unknown peaks components are identified.

Serum Biochemical Parameters Analysis

The effects of purslane seed consumption and aerobic on the serum biochemicals of diabetic women are presented in Table 3. Blood glucose, LDL, Cholesterol, and TG concentration in the (PS), (AT + PL), (AT + PS) groups were significantly decreased after 16 weeks as compared to pre-experimental levels or the (PL) (p < 0.05). No significant differences observed between (PS) and (AT + PL) (p > 0.05), whereas significant interactions were detected between (PS) and (AT + PL) compared to (AT + PS) (p < 0.05).
Table 3

Changes in the serum variables of diabetic subjects between 4 groups pre and post 16 weeks experiments.

VariableStagePlacebo (PL) Mean ± SEMAerobic Training + Placebo (AT + PL) Mean ± SEMPurslane Seeds (PS) Mean ± SEMAerobic Training + Purslane Seeds (AT + PS) Mean ± SEM
Glucose, mg/dLPre Post168.2 ± 18.1164.8 ± 17.5167.4 ± 14.1167.6 ± 20.6
173.1 ± 19.7147.3 ± 18.3*,†152.1 ± 11.9*,140.1 ± 15.2*,,#,
LDL-C, mg/dLPre Post83.3 ± 8.687.1 ± 12.484.1 ± 14.286.3 ± 11.7
82.1 ± 19.775.5 ± 17.2*,79.9 ± 12.6*,72.8 ± 19.7*,,#,
HDL-C, mg/dLPre Post35.8 ± 4.936.7 ± 8.335.3 ± 7.234.9 ± 3.7
33.6 ± 9.139.8 ± 10.3*,39.2 ± 6.9*,46.7 ± 7.4*,,#,
Cholesterol, mg/dLPre Post197.2 ± 22.4198.5 ± 26.1196.9 ± 22.6198.7 ± 24.8
209.2 ± 20.1169.7 ± 14.8*,172.3 ± 19.3*,155.2 ± 16.4*,,#,
TG, mg/dLPre Post183.1 ± 26.3182.8 ± 21.7183.6 ± 27.2183.1 ± 23.8
182.9 ± 24.7152.7 ± 29.2*,159.3 ± 22.0*,142.2 ± 21.5*,,#,
Creatinine, mg/dLPre Post1.43 ± 0.041.41 ± 0.051.40 ± 0.051.41 ± 0.03
1.43 ± 0.020.81 ± 0.06*,0.88 ± 0.06*,0.42 ± 0.07*,,#,
Urea, mg/dLPre Post19.31 ± 1.1918.99 ± 1.0418.86 ± 0.8219.01 ± 0.63
19.31 ± 1.1114.21 ± 0.98*,14.42 ± 0.07*,10.62 ± 0.98*,,#,
Uric Acid mg/dLPre Post4.65 ± 0.154.82 ± 0.184.59 ± 0.164.71 ± 0.15
4.66 ± 0.423.38 ± 0.21*,3.11 ± 0.14*,2.39 ± 0.23*,,#,

*Denote significant differences from pre-test.

†Denote significant differences from Placebo group.

#Denote significant differences from Aerobic Training+ Placebo.

ΩDenote significant differences from Purslane Seeds group.

p < 0.05 as compared to pre-test, Placebo, Aerobic Training+ Placebo, and Purslane Seeds groups.

However, the HDL levels significantly increased in all (PS), (AT + PL), (AT + PS) groups as compared to pre-experimental levels or the (PL) (p < 0.05). No significant differences observed between (PS) and (AT + PL) (p > 0.05), whereas significant distinction were detected in (PS) and (AT + PL) compared to (AT + PS) (p < 0.05). The changes were more pronounced in (AT + PS) group. Furthermore, Creatinine, Urea, and Uric Acid in the (PS), (AT + PL), (AT + PS) groups were significantly decreased after 16 weeks as compared to the pre experimental levels or the (PL) (p < 0.05). No significant differences observed between (PS) and (AT + PL) (p > 0.05), while significant distinction were detected in (PS) and (AT + PL) compared to (AT + PS) (p < 0.05). The reductions in levels were more pronounced in (AT + PS) group.

Atherosclerosis Biomarkers

The effects of purslane seed consumption and aerobic on the serum protein and mRNA biomarkers changes in diabetic women are presented in Table 4 and Figs 3, 4 and 5. The protein and mRNA concentration levels of NF-κB, TIMP-1, MMP 2 & 9, CRP, CST3, and CTSS in the (PS), (AT + PL), (AT + PS) had significantly decreased after 16 weeks as compared to the pre experimental levels or the (PL) (p < 0.05). No significant differences observed between (PS) and (AT + PL) in the protein and mRNA concentration levels of NF-κB, MMP2 &9, CRP, CST3, and CTSS (p > 0.05), while significant distinction were detected in (PS) and (AT + PL) compared to (AT + PS) (p < 0.05). In addition, a significant difference observed between (PS) and (AT + PL) in the protein and mRNA concentration levels of TIMP-1, as well as significant distinction in (PS) and (AT + PL) compared to (AT + PS) (p < 0.05).
Table 4

Changes in the Serum biomarkers concentration diabetic subjects between 4 groups pre and post 16 weeks experiments.

VariableStagePlacebo (PL) Mean ± SEMAerobic Training+ Placebo (AT + PL) Mean ± SEMPurslane Seeds (PS) Mean ± SEMAerobic Training+Purslane Seeds (AT + PS) Mean ± SEM
NF-κB1, ng/mLPre Post8.74 ± 0.78.87 ± 0.58.52 ± 0.58.79 ± 0.6
8.69 ± 0.2 6.7 ± 0.3$,β6.5 ± 0.4$,β5.3 ± 0.4$,β,,£
GLP1, ng/mLPre Post5.44 ± 0.34.38 ± 0.63.82 ± 0.33.43 ± 0.3
5.55 ± 0.45.78 ± 0.3$,β 4.93 ± 0.6$,β,5.77 ± 0.7$,β,,£
GLP1-R, ng/mLPre Post0.56 ± 0.0120.52 ± 0.0160.48 ± 0.0170.49 ± 0.011
0.59 ± 0.0180.69 ± 0.013$,β 0.67 ± 0.015$,β0.71 ± 0.014$,β,,£
TIMP-1, ng/mLPre Post10.72 ± 0.5610.47 ± 0.4710.22 ± 0.6810.86 ± 0.87
10.69 ± 0.66.98 ± 0.95$,†,β7.84 ± 0.44$,β, 5.12 ± 0.65$,β,,£
MMP2, ng/mLPre Post0.88 ± 0.020.87 ± 0.030.88 ± 0.020.86 ± 0.02
0.87 ± 0.030.70 ± 0.04$,†,β0.67 ± 0.03$,β0.55 ± 0.04$,β,,£
MMP9, ng/mLPre Post1.62 ± 0.051.59 ± 0.071.58 ± 0.081.60 ± 0.07
1.61 ± 0.041.08 ± 0.22$,†,β1.05 ± 0.15$,β0.55 ± 0.19$,β,,£
CRP, mg/mLPre Post8.72 ± 0.47.91 ± 0.67.85 ± 0.68.56 ± 0.7
8.83 ± 0.56.1 ± 0.3$,β 6.2 ± 0.1$,β 5.1 ± 0.3$,β,,£
CST3, ng/mLPre Post35.13 ± 4.3235.33 ± 3.5234.71 ± 4.6134.51 ± 3.22
35.75 ± 3.2526.25 ± 3.95$,β25.98 ± 2.44$,β20.09 ± 3.65$,β,,£
CTSS, ng/mLPre Post0.77 ± 0.020.76 ± 0.030.79 ± 0.060.79 ± 0.03
0.77 ± 0.020.64 ± 0.05$,β0.61 ± 0.02$,β0.29 ± 0.02$,β,,£

$Denote significant differences from pre-test.

βDenote significant differences from Placebo group.

€Denote significant differences from Aerobic Training+ Placebo.

£Denote significant differences from Purslane Seeds group.

p < 0.05 as compared to pre-test, Placebo, Aerobic Training+ Placebo, and Purslane Seeds groups.

Figure 3

Blood CRP, NF-κB, GPL-1, and GPL1-R, mRNA expression and activity at pre or post treatment in diabetic type 2 women. Data were expressed as mean ± SEM.

PL; Placebo, PL + A; Placebo + Aerobic, PS; Purslane Seed, and A + PS; Aerobic + Purslane Seed. *p < 0.05 as compared to Placebo group.

Figure 4

Blood MMP-2, MMP-9, and TMP-1 mRNA expression and activity at pre or post treatment in diabetic type 2 women. Data were expressed as mean ± SEM.

PL; Placebo, PL + A; Placebo + Aerobic, PS; Purslane Seed, and A + PS; Aerobic + Purslane Seed. *p < 0.05 as compared to Placebo group.

Figure 5

Blood CST3 and CTSS mRNA expression and activity at pre or post treatment in diabetic type 2 women.

Data were expressed as mean ± SEM. PL; Placebo, PL + A; Placebo + Aerobic, PS; Purslane Seed, and A + PS; Aerobic + Purslane Seed. *p < 0.05 as compared to Placebo group.

Furthermore, GLP1 and GLP1-R had profoundly increased in the (PS), (AT + PL), (AT + PS) as compared to the pre experimental levels or the (PL) (p < 0.05). No significant difference observed between (PS) and (AT + PL) in the protein and mRNA concentration levels of GLP1-R (p > 0.05), while a significant difference observed between (PS) and (AT + PL) in the protein and mRNA concentration levels of GLP1 (p < 0.05). Moreover, significant distinction were detected in the protein and mRNA concentration levels of GLP1 and GLP1-R in (PS) and (AT + PL) compared to (AT + PS) (p < 0.05). The changes were more pronounced in (AT + PS) group.

Discussion

The control and treatment of diabetes and its complications predominantly depends on chemical or biochemical agents. However, total recovery from diabetes has never been reported3839. The data from the current study showed that 16 weeks of aerobic training or purslane seed consumption ere effective in reduction of markers of inflammations such as NF-κB, CRP, CST3, CTSS, MMP 2 & 9 and TIMP-1 in diabetic patients. In addition, glucose, TG, LDL, urea, uric acid and creatinine levels in all treated groups were significantly reduced. Furthermore, there was an increase in the levels of HDL, GLP-1 and GLP-1R. The improvement was more remarkable in women who received training and supplementation simultaneously. The changes in the level of biomarkers were further evaluated by the expression of mRNA from blood samples of the same subjects. Our results show that the mRNA levels of NF-κB, CRP, CST3, CTSS, MMP 2, 9 and TIMP-1 increased after intervention. GC-MS analyses results indicated the presence of 21 compounds, of which 27% are poly unsaturated fatty acid (linoleic and palmetoleic acid) and 11.18% are phytosterols (stiotestrol). The observed effects of purslane seeds may be due to the presence of these compounds. The findings suggest that glucose levels had decreased in all groups. However the decrease was more evident in the group consuming purslane seed and exercising simultaneously. Purslane seed consumption has been shown previously to impact glucose levels27. High levels of glucose in diabetes appears to be an initiating factor for the eventual cascade of biomarkers involved in inflammation and coronary heart diseases. Improvements in lipid profile were observed in the subjects after 16 weeks of aerobic training or purslane seed consumption or both (Table 3). The reduction of lipid profile in the aerobic group could be due to the decrease of free fatty acids, which negatively affect insulin resistance and excess lipid availability404142434445. Hence, aerobic training is beneficial for patients with T2D404246. The results obtained from our study also highlights the positive effects of purslane seed consumption on TG, LDL, cholesterol and HDL levels, which is consistent with earlier reports in T2D of Yemeni and Iranian patients531. Levels of blood urea, uric acid and creatinine (Table 3) were reduced in all treated groups. In T2D overweight patients, uric acid and urea serve as biomarkers for impaired physical performances and are associated with blood glucose levels47. Purslane consumption in T2D mice48 and T2D women has also been shown to reduce levels of creatinine, uric acid and urea49. Therefore, the reduction of blood nitrogen content seen in this study, may be lined to reduction in glucose levels (Table 3) following purslane seed consumption or aerobic training. In a study reported by Sousa50, twelve weeks of resistance training improved uric acid levels in T2D in Brazilian patients50515253. However, six months of aerobic training did not produce remarkable effects on creatinine and urea in untrained aged healthy women54. The current study highlighted the beneficial effects of purslane seed consumption in alleviation of diabetes parameters. The beneficial effect may due to the presence of unsaturated fatty acids and beta-sistosterol as identified via GC-MS analysis (Table 2 and Fig. 2). Previous reports have suggested that, unsaturated fatty acids are responsible in reducing levels of LDL and cholesterol synthesis55, enhancing insulin function56 and improving glucose tolerance and lipid profile5758. Another active substance in purslane seed is beta-sitosterol which is a phytosterol. Studies have found that beta-sitosterol has cholesterol59 and LDL60 lowering effects, increases the expression of VEGF (vascular endothelial growth factor) and FLK-1 (Fetal Liver Kinase 1) of VEGF receptors while modulating inflammation and regulation the immune systems. The effectiveness of purslane seed consumption is in lowering cholesterol levels explained by the synergistic effect of both phytosterols and unsaturated fatty acids61. Hyperglycemia, hyperlipidemia, hyperinsulinemia171853 and hyperuricemia626364 of diabetics are common symptoms which enhance production of pro inflammatory markers such as CRP, IL6, TNFα, NF-κB1718536264, reactive oxygen species (ROS) and reduce anti-inflammatory cytokine and adiponectin, which are involved in insulin resistance1665 and diabetes66. Reduction in the level of NF-κB and CRP in the inflammatory cascade was observed in treated groups of diabetics’ subjects. Our experiments showed that purslane seed consumption resulted in reduction of CRP and NF-κB (Table 4 and Fig. 3). This may be the result of inhibitory effects of unsaturated fatty acids on NF-κB reported in diabetic patients67. The inhibitory effect of unsaturated fatty acids such as omega 3 on CRP68 in diabetic patients was reported even though the changes in CRP level were not significant. However, the significant reduction of CRP in the present study may indicate synergistic effect of various compounds found in purslane seed. Reduction in the level of CRP following resistance or strength training has been reported in patients with kidney disease4569, older adults with T2D21 and diabetic men70 and in improving insulin sensitivity21. Various types of exercise may affect levels of NFκB differently. For instance, acute exercise did not change the level of NFκB in T2D patients53, but acute treadmill running raised the level of NFκB activity in rat skeletal muscles71. Therefore, reduction in levels of NFκB may be linked to CRP level reduction following aerobic exercise (Table 4) by impact on different synergistically pathways525372. The expression of NFκB and CRP are interconnected whereby CRP enhances NFκB levels9, thus aerobic training and/or purslane seed consumption may directly or indirectly reduce the levels of NFκB via reducing the CRP. The reduction of these two biomarkers is associated with the levels of inflammation and ROS in addition to regulation of ECM918. Matrix metalloproteinase (MMPs) and cathepsin S (CTSS) are proteases that degrade at least one component ECM and contribute for tissue remodeling and inflammation. Higher level of CRP and IL-6 are associated with higher level of CTSS17 and higher levels of NFκB enhance MMPs level1673. In pathological conditions such as diabetes, the balance between the protease enzymes (MMPs and CTSS) and their inhibitors (metallopeptidase inhibitor 1; TIMP-1 and CST3) are dysregulated74. The concentrations of MMP-2, 9 and TIMP-1 has been shown higher in T2D patients as compared to non-diabetic subjects7576 but in the current study, their levels were significantly reduced in all treated groups following different interventions (Table 4 and Fig. 4). Positive effects of exercise improve the balance between pro- and anti-inflammatory and oxidative stress markers which could improve nitric oxide bioavailability and alter MMPs and/or tissue inhibitors of MMPs (TIMP) activity. Chronic exercise training, that acts as a mechanical stressor for the arteries, could exert its effects by altering MMP/TIMPs activity directly and/or indirectly via the anti-inflammatory and oxidative stress responses of exercise77. The finding were concurrent with those of Kim et al.18 which states that the level of MMP-2 was reduced after low intensity exercise training in diabetic mice78. The suppressive effect of purslane seed on MMP and TIMP activity may be caused by the presence of the unsaturated fatty acids in the seeds. Similar outcomes were observed in patients with multiple sclerosis79 and in pregnant rats80. CTSS is another important regulator of inflammation14 that plays a role in pathological conditions such as diabetes1781. This regulator and its inhibitor CST3 are higher in diabetic patients as compared to healthy subjects82. Nonetheless the current interventions applied in this study reduced the protein and mRNA of both CTSS and CST3 (Table 4 and Fig. 5). This reduction following exercise may changes energy balance in adipose tissues83. Moreover, CTSS is positively correlated with weight loss8384 and TG level in obese subjects85. Reduction in CTSS and LDL was also observed in diet induced weight loss in non-obese men and women86. This further supports the hypothesis that CTSS contributes to cardiovascular risks in obesity83. The reduction of CTSS and CST3 was also observed in the group consuming purslane seed alone which could be due to the presence of unsaturated fatty acids and beta-sistosterol found in the seeds. However, the mechanism of for their reduction is unknown. This study also evaluated the effect of intervention on biomarkers for insulin and beta cell activity. The levels of GLP-1 and GLP-1R were measured. GLP-1 is an insulinotropic in T2D which improves insulin secretion via it’s receptor and by stimulation of glucose dependent insulin secretion19. It also has protective effect against degradation of ECM20 and inhibits apoptosis of beta cells87. In addition GLP-1 mimetics are potential drugs to treat T2D88. The present findings, showed improving effects of interventions on GLP-1 and its receptor levels (Table 4 and Fig. 3). This is possibly linked to effects of purslane and aerobic training on beta cells mediated by the AMPK activated pathway8889. Exercise and physical activity induce the AMPK pathway and inhibit energy consuming pathways such as fatty acid and cholesterol synthesis and stimulate the ATP catabolic pathway90. Since AMPK signaling pathway is among the crucial pathways involved in inflammation, following activation of this pathway, inhibition of NFκB and its downstream signaling pathway occurs91. Thus the reduction in the inflammatory state of diabetes may be an important factor leading to improved insulin sensitivity and better metabolic control21. Increased physical activity and weight loss are associated with lower CRP and reduction in concentration of other markers of inflammation3392. Therefore, both intervention alone or in combination might act through AMPK pathway and inhibit the activation of downstream inflammation through inhibition of CRP and NFκB. Among different insulin signaling pathways, available treatments for diabetes usually trigger the AMPK pathway which is insulin independent93 and metformin activated that results in the inhibition of NF-kB activity in endothelial cells9495. In this study, the level of NF-kB as a master inflammation key was reduced with purslane intake and/or aerobic training which could be due to activation of the AMPK pathway. Previous reports have indicated that aerobic exercise5253 and the uptake of unsaturated fatty acids activate the AMP and AMPK pathways96.

Conclusion

The data obtained from this study indicated that 16 weeks of aerobic training or/and purslane seed consumption ere effective in regulation of diabetic parameters and biomarkers associated with atherosclerosis in women with T2D. This may be due to the synergistic effect of aerobic training and unsaturated fatty acids found in purslane seed which activate the AMP and AMPK pathways. This may result in the regulation of biomarkers involved in cardiovascular complications of T2D. The parallel effects of purslane intake and aerobic training in their simultaneous role were more prominent which could be a strong therapeutic effective factor on diabetic patients with CVD. Thus, with the benefits of this combination on reducing health risk factors, diabetic patients are advised to exploit this arrangement of alternative to control and manage their disease. However, further investigations are warranted, and such research should focus on identifying the specific properties of purslane seed, proper dose, role of various active compounds, as well as the possibilities for synergistic interactions not only between the various components of this seed, but also between various alternatives in treating and reducing symptoms of these diseases.

Additional Information

How to cite this article: Dehghan, F. et al. Purslane (Portulaca oleracea) Seed Consumption And Aerobic Training Improves Biomarkers Associated with Atherosclerosis in Women with Type 2 Diabetes (T2D). Sci. Rep. 6, 37819; doi: 10.1038/srep37819 (2016). Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
  89 in total

1.  Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA- cp rat model of the metabolic syndrome.

Authors:  Jing Lu; Faye Borthwick; Zahra Hassanali; Ye Wang; Rabban Mangat; Megan Ruth; Danni Shi; Anja Jaeschke; James C Russell; Catherine J Field; Spencer D Proctor; Donna F Vine
Journal:  Br J Nutr       Date:  2011-01-31       Impact factor: 3.718

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease.

Authors:  Salvatore Santo Signorelli; Grazia Malaponte; Massimo Libra; Luigi Di Pino; Gabriella Celotta; Valentina Bevelacqua; Marcello Petrina; Giuseppina S Nicotra; Manuela Indelicato; Patrick M Navolanic; Giuseppe Pennisi; Maria Clorinda Mazzarino
Journal:  Vasc Med       Date:  2005-02       Impact factor: 3.239

4.  Serum cystatin C as a biomarker for predicting coronary artery disease in diabetes.

Authors:  Jee-Young Oh
Journal:  Korean Diabetes J       Date:  2010-04-30

5.  The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjects.

Authors:  C Watala; P D Winocour
Journal:  Eur J Clin Chem Clin Biochem       Date:  1992-09

6.  Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey.

Authors:  Shamima Akter; M Mizanur Rahman; Sarah Krull Abe; Papia Sultana
Journal:  Bull World Health Organ       Date:  2014-01-10       Impact factor: 9.408

Review 7.  Diabetes and hypertension: is there a common metabolic pathway?

Authors:  Bernard M Y Cheung; Chao Li
Journal:  Curr Atheroscler Rep       Date:  2012-04       Impact factor: 5.113

8.  Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008.

Authors:  Markku Laakso
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

Review 9.  Targeting the AMPK pathway for the treatment of Type 2 diabetes.

Authors:  Benoit Viollet; Louise Lantier; Jocelyne Devin-Leclerc; Sophie Hebrard; Chloe Amouyal; Remi Mounier; Marc Foretz; Fabrizio Andreelli
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes.

Authors:  Lorenzo A Gordon; Errol Y Morrison; Donovan A McGrowder; Ronald Young; Yeiny Terry Pena Fraser; Eslaen Martorell Zamora; Ruby L Alexander-Lindo; Rachael R Irving
Journal:  BMC Complement Altern Med       Date:  2008-05-13       Impact factor: 3.659

View more
  7 in total

1.  Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis.

Authors:  Kaushik Chattopadhyay; Haiquan Wang; Jaspreet Kaur; Gamze Nalbant; Abdullah Almaqhawi; Burak Kundakci; Jeemon Panniyammakal; Michael Heinrich; Sarah Anne Lewis; Sheila Margaret Greenfield; Nikhil Tandon; Tuhin Kanti Biswas; Sanjay Kinra; Jo Leonardi-Bee
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

Review 2.  Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis.

Authors:  Rubens P Homme; Mahavir Singh; Avisek Majumder; Akash K George; Kavya Nair; Harpal S Sandhu; Neetu Tyagi; David Lominadze; Suresh C Tyagi
Journal:  Front Physiol       Date:  2018-09-05       Impact factor: 4.566

3.  An Integrative Pharmacology-Based Approach for Evaluating the Potential Effects of Purslane Seed in Diabetes Mellitus Treatment Using UHPLC-LTQ-Orbitrap and TCMIP V2.0.

Authors:  Jinli Hou; Xiang Zhou; Ping Wang; Chunhui Zhao; Yuewen Qin; Feng Liu; Liping Yu; Haiyu Xu
Journal:  Front Pharmacol       Date:  2021-02-02       Impact factor: 5.810

4.  Effects of Exercise on Inflammatory Cytokines in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials.

Authors:  Xiaoke Chen; Xinzheng Sun; Chenghao Wang; Hui He
Journal:  Oxid Med Cell Longev       Date:  2020-12-28       Impact factor: 6.543

5.  Identification of Monocyte-Associated Genes Related to the Instability of Atherosclerosis Plaque.

Authors:  Wentao Qin; Fu Gan; Riguan Liang; Jing Li; Xiaomei Lai; Yongfa Dai; Jie Liu
Journal:  Oxid Med Cell Longev       Date:  2022-09-21       Impact factor: 7.310

6.  The Activation of ROS/NF-κB/MMP-9 Pathway Promotes Calcium-Induced Kidney Crystal Deposition.

Authors:  Yue Wu; Jiaqiao Zhang; Cong Li; Henglong Hu; Baolong Qin; Tao Wang; Yuchao Lu; Shaogang Wang
Journal:  Oxid Med Cell Longev       Date:  2021-06-08       Impact factor: 6.543

7.  Influence of Green Leafy Vegetables in Diets with an Elevated ω-6:ω-3 Fatty Acid Ratio on Rat Blood Pressure, Plasma Lipids, Antioxidant Status and Markers of Inflammation.

Authors:  Melissa Johnson; Wendell H McElhenney; Marceline Egnin
Journal:  Nutrients       Date:  2019-01-31       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.